The effect of different diagnostic criteria on the prevalence of dementia

New England Journal of Medicine

Volumn 337, Issue 23, 1997, Pages 1667-1674

  Erkinjuntti, Timo ^a   Østbye, Truls ^b   Steenhuis, Runa ^b,c   Hachinski, Vladimir ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS;

AGED; AGED, 80 AND OVER; CANADA; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0030666458     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199712043372306     Document Type: Article

References (32)

1. Østbye T, Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J 1994;151:1457-64. [Erratum, Can Med Assoc J 1995;152: 158.]
2. Henderson AS, Jorm AF, Mackinnon A, et al. A survey of dementia in the Canberra population: experience with ICD-10 and DSM-III-R criteria. Psychol Med 1994;24:473-82.
3. Mental and behavioural disorders (F00-F99). In: The international classification of diseases, 10th rev.: ICD-10. Geneva: World Health Organization, 1992:311-88.
4. Diagnostic and statistical manual of mental disorders, 3rd ed. rev.: DSM-III-R. Washington, D.C.: American Psychiatric Association, 1987.
5. Fichter MM, Meller I, Schröppel H, Steinkirchner R. Dementia and cognitive impairment in the oldest old in the community: prevalence and comorbidity. Br J Psychiatry 1995;166:621-9
6. Diagnostic and statistical manual of mental disorders, 3rd ed.: DSM-III. Washington, D.C.: American Psychiatric Association, 1980.
7. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
8. International classification of diseases: manual of the international statistical classification of diseases, injuries, and causes of death: based on recommendations of the Ninth Revision Conference, 1975, and adopted by the Twenty-ninth World Health Assembly. Geneva: World Health Organization, 1977.
9. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
10. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899-913.
11. Teng EL, Chui HC. The modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-8.
12. Tuokko H, Kristjansson E, Miller J. The neuropsychological detection of dementia: an overview of the neuropsychological component of the Canadian Study of Health and Aging. J Clin Exp Neuropsychol 1995;17:352-73.
13. Steenhuis RE, Østbye T. Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol 1995;17:773-85.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
15. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76: 465-79.
16. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41:1886-92.
17. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke: baseline frequency and effect of different definitions for dementia in the Helsinki Aging Memory Study (SAM) cohort. Stroke 1997;28:785-92.
18. Tatemichi TK, Desmond DW, Stern Y, Sano M, Mayeux R, Andrews H. Prevalence of dementia after stroke depends on diagnostic criteria. Neurology 1992;42:Suppl 3:413. abstract.
19. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
20. Cummings JL, Benson DF, eds. Dementia: a clinical approach. 2nd ed. Stoneham, Mass.: Butterworth-Heinemann, 1992.
21. Wetterung T, Kanitz R-D, Borgis K-J. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30-6.
22. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328: 153-8.
23. Schuckit MA, Hesselbrock V, Tipp J, Anthenelli R, Bucholz K, Radziminski S. A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1922 men and women subjects in the COGA study: Collaborative Study on the Genetics of Alcoholism. Addiction 1994;89:1629-38.
24. Bronisch T, Mombour W. Comparison of a diagnostic checklist with a structured interview for the assessment of DSM-III-R and ICD-10 personality disorders. Psychopathology 1994;27:312-20.
25. Tomasson K, Kent D, Coryell W. Comparison of four diagnostic systems for the diagnosis of somatization disorder. Acta Psychiatr Scand 1993; 88:311-5.
26. Hiller W, Dichtl G, Hecht H, Hundt W, von Zerssen D. Testing the comparability of psychiatric diagnoses in ICD-10 and DSM-III-R. Psychopathology 1994;27:19-28.
27. Hachinski VC. Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645-8.
28. Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis 1993;3:3-23.
29. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993;50:305-10.
30. Soininen HS, Riekkinen PJ Sr. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 1996;19:224-8.
31. Saunders AM, Hulette O, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-3.
32. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-7.